Physician profile
Carmen M Oconnor
NPI 1841287067
$3,939.21
in general payments reported to CMS, 2019-2025
29 companies · $804 in 2025
The $804 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $620 · 2023: $1,044 · 2024: $1,062 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,810.47 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,019.60 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $403.81 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $311.34 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.24 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $275.17 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $260.32 | 2021-2023 | Xarelto |
| Abiomed | $206.41 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $194.08 | 2022-2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $170.02 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Edwards Lifesciences Corporation | $169.94 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $121.17 | 2023 | |
| Kestra Medical Technology Services, INC. | $78.67 | 2024-2025 | Assure Wcd |
| Pfizer INC. | $69.64 | 2022-2024 | |
| Scpharmaceuticals INC. | $40.52 | 2023-2025 | |
| Boston Scientific Corporation | $39.43 | 2025 | General - Crm_crm |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $38.75 | 2023 | Arcalyst |
| Biosense Webster, INC. | $34.50 | 2024 | Carto 3 |
| Regeneron Healthcare Solutions, INC. | $21.72 | 2025 | Praluent, Evkeeza |
| Medtronic, INC. | $21.67 | 2025 | Micra |
| E.R. Squibb & Sons, L.L.C. | $21.64 | 2025 | Camzyos |
| Csl Behring | $20.84 | 2023 | Kcentra |
| Sanofi-Aventis U.S. LLC | $20.34 | 2024 | |
| Hologic Sales and Service, LLC | $18.37 | 2024 | Thinprep 2000 Processor, Third Wave, Aptima |
| Astrazeneca Pharmaceuticals LP | $17.53 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $16.45 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $15.18 | 2023 | Inpefa |
| Cvrx, INC. | $14.81 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.73 | 2023 | Jardiance |
| Amarin Pharma, INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.